Neurobo Pharmaceuticals Inc Stock Ownership - Who owns Neurobo Pharmaceuticals?

Insider buying vs selling

Have Neurobo Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NRBO insiders and whales buy or sell their stock.

NRBO Shareholders

What type of owners hold Neurobo Pharmaceuticals Inc stock?
Na Yeon Kim125.94%6,178,535$25.08MInsider
Einvestment Inc122.64%6,016,669$24.43MInsider
Donga St Co Ltd58.72%2,880,612$11.70MInsider
Jeong Gyun Oh41.95%2,057,893$8.36MInsider
Charles Phd Bisgaier29.56%1,450,362$5.89MInsider
Steven R. Phd Gullans25.08%1,230,252$4.99MInsider
Goldman Sachs Group Inc24.88%1,220,502$4.96MInsider
Akash Bakshi18.61%913,085$3.71MInsider
David Lowenschuss16.43%806,247$3.27MInsider
Jk Biopharma Solutions Inc16.31%800,170$3.25MInsider

1 of 3

NRBO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITRM3.99%96.01%Net Buying
INDP6.88%84.59%Net Buying
MEIP16.55%83.45%Net BuyingNet Buying

Neurobo Pharmaceuticals Stock Ownership FAQ

Who owns Neurobo Pharmaceuticals?

Neurobo Pharmaceuticals (NASDAQ: NRBO) is owned by 1.98% institutional shareholders, 523.80% Neurobo Pharmaceuticals insiders, and 0.00% retail investors. Na Yeon Kim is the largest individual Neurobo Pharmaceuticals shareholder, owning 6.18M shares representing 125.94% of the company. Na Yeon Kim's Neurobo Pharmaceuticals shares are currently valued at $25.08M.

If you're new to stock investing, here's how to buy Neurobo Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.